Arcturus Therapeutics Holdings Inc’s recent filing unveils that its Chief Scientific Officer & COO Chivukula Pad unloaded Company’s shares for reported $0.61 million on Mar 25 ’24. In the deal valued at $35.02 per share,17,435 shares were sold. As a result of this transaction, Chivukula Pad now holds 473,448 shares worth roughly $13.22 million.
Then, Chivukula Pad sold 8,565 shares, generating $299,839 in total proceeds. Upon selling the shares at $35.01, the Chief Scientific Officer & COO now owns 490,883 shares.
Before that, Chivukula Pad sold 5,000 shares. Arcturus Therapeutics Holdings Inc shares valued at $93,602 were divested by the Chief Scientific Officer & COO at a price of $18.72 per share. As a result of the transaction, Chivukula Pad now holds 499,448 shares, worth roughly $13.95 million.
Canaccord Genuity initiated its Arcturus Therapeutics Holdings Inc [ARCT] rating to a Buy in a research note published on December 13, 2023; the price target was $90. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ARCT and has increased its forecast on May 11, 2023 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of ARCT
On Tuesday, Arcturus Therapeutics Holdings Inc [NASDAQ:ARCT] saw its stock jump 3.22% to $27.93. Over the last five days, the stock has lost -7.30%. Arcturus Therapeutics Holdings Inc shares have fallen nearly -11.42% since the year began. Nevertheless, the stocks have risen 0.90% over the past one year. While a 52-week high of $43.81 was reached on 02/27/24, a 52-week low of $17.52 was recorded on 04/19/24. SMA at 50 days reached $34.60, while 200 days put it at $29.98. A total of 0.31 million shares were traded, compared to the trading of 0.33 million shares in the previous session.
Levels Of Support And Resistance For ARCT Stock
The 24-hour chart illustrates a support level at 27.04, which if violated will result in even more drops to 26.15. On the upside, there is a resistance level at 28.81. A further resistance level may holdings at 29.69. The Relative Strength Index (RSI) on the 14-day chart is 38.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.97%. Stochastics %K at 18.07% indicates the stock is a buying.
